- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
A New Decision Support Tool for Surgical Oncology Launched
A pathways company has followed up its medical and radiation oncology clinical decision tools with a new surgical oncology platform.
Clinical pathways are rapidly being adopted by providers and payers alike, to guide treatment decisions and also manage care costs. Via Oncology, a company that develops these clinical pathways using its in-house expertise of physicians, has announced the launch of a Surgical Oncology Pathways platform, which follows similar platforms for medical and radiation oncology.
In an associated press release the company said that the new platform is initially being rolled out at UPMC and Indiana University Health, for 6 diseases, incorporating key decision points for patient work-up and assessment along with surgical interventions and follow up surveillance plans.
According to Kathy Lokay, CEO and President of Via Oncology, “The Via Pathways program has been central to the quality of care in medical and radiation oncology and we are excited to expand it for use by surgical oncologists as well.”
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Exploring Possibilities in Disease Modification in MPNs
October 25th 2024Experts are asking whether the study and treatment of myeloproliferative neoplasms (MPNs) is ready for a new era with new end points, with data that show how survival benefits are biologically linked to changes in the spleen, reduction in fibrosis, or other responses.
Read More
Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value
July 18th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.
Listen
Recognizing Symptoms of Myeloproliferative Neoplasms and Clinical Trial Challenges
October 24th 2024There can be a delay in diagnosis of myeloproliferative neoplasms as the symptoms of the diseases can be variable and common, such as fatigue, migraines, and difficulty concentrating, explained Ruben Mesa, MD, of Atrium Health.
Read More
Prediagnosis Diet Improves Survival in Black Women With Deadly Ovarian Cancer
October 24th 2024Moderate prediagnosis adherence to dietary guidelines was associated with improved survival rates among Black women with high-grade serous ovarian cancer, the most common and lethal type of ovarian cancer.
Read More
